Advertisement
Journal of Biological Chemistry
Open access logo
Advanced SearchSave search
ARTICLE| Volume 248, ISSUE 18, P6490-6505, September 25, 1973

The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor

Open AccessPublished:September 25, 1973DOI:https://doi.org/10.1016/S0021-9258(19)43472-8
The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor
Previous ArticleMalate Dehydrogenase
Next ArticleGlycoprotein Enzymes Secreted by Aspergillus fumigatus
      This paper is only available as a PDF. To read, Please Download here.
      A procedure is presented for purifying antithrombin-heparin cofactor from human plasma. The final product is homogeneous as judged by disc gel electrophoresis, sodium dodecyl sulfate gel electrophoresis, and immunoelectrophoresis. The final yield averages 12%. A specific antibody directed against pure inhibitor preparations precipitates virtually all of both antithrombin and heparin cofactor activity from defibrinated plasma. The purification, the immunoprecipitation, and other data, indicate that both activities are properties of a single molecular species.
      The inhibitor and thrombin form a 1:1 stoichiometric complex which cannot be dissociated with denaturing and reducing agents. Addition of heparin, a widely used anticoagulant which specifically accelerates the action of our inhibitor, increases the rate of formation of this complex without altering its stoichiometry or its dissociability. Interaction of thrombin with antithrombin-heparin cofactor requires the presence of the active center serine of the enzyme and arginine residue(s) on the inhibitor, since chemical modification of either of these critical residues inhibits complex formation both in the presence and absence of heparin. We suggest that, in analogous fashion to trypsin-trypsin inhibitor systems, a specific interaction occurs between the active center serine of thrombin and a unique arginine-x reactive site on the antithrombin-heparin cofactor.
      Furthermore, lysyl residues of the inhibitor probably serve as a binding site for heparin, since chemical modification of these residues virtually eliminates heparin cofactor activity with only minimal reduction of antithrombin activity. We postulate that heparin binds to the inhibitor and causes a conformational change which results in a more favorable exposure of the arginine reactive site, allowing a rapid interaction with thrombin.

      REFERENCES

        • Contejean C.
        Arch. Physiol. Norm. Pathol. 1895; 7: 45-53
        • Morawitz P.
        The Chemistry of Blood Coagulation. Charles C Thomas, Springfield, Illinois1968
        • Howell W.H.
        Harvey Led. 1916; 2: 272-323
        • Seegers W.H.
        • Johnson J.F.
        • Fall C.
        Amer. J. Physiol. 1954; 176: 97-103
        • McLean J.
        Amer. J. Physiol. 1916; 41: 250-257
        • Brinkhous K.
        • Smith H.P.
        • Warner E.D.
        • Seegers W.H.
        Amer. J. Physiol. 1939; 125: 683-687
        • Waugh D.F.
        • Fitzgerald M.A.
        Amer. J. Physiol. 1956; 184: 627-638
        • Monkhouse F.C.
        • France E.S.
        • Seegers W.H.
        Circ. lies. 1955; 3: 397-402
        • Abildgaabd U.
        Scand. J. Clin. Lab. Invest. 1968; 21: 89-91
        • Biggs I.L.
        • Denson K.W.E.
        • Akman N.
        • Bobrett R.
        • Hadden M.
        Brit. J. Haematol. 1970; 19: 283-305
        • Seegers W.H.
        • Cole E.R.
        • Harmison C.R.
        • Monkhouse F.C.
        Can. J. Biochem. 1964; 42: 359-364
        • Yin E.T.
        • Wessler S.
        • Stoll P.J.
        J. Biol. Chem. 1971; 246: 3694-3702
        • Lindahl U.
        • Cifonelli L.A.
        • Lindahl B.
        • Roden L.
        J. Biol. Chem. 1965; 240: 2817-2820
        • Shapiro S.S.
        • Waugh D.F.
        Thromb. Diath. Haemorrh. 1966; 16: 469-490
        • Ware A.G.
        • Seegers W.H.
        Amer. J. Physiol. 1948; 152: 567-576
        • Quick A.J.
        J. Amer. Med. Assoc. 1938; 110: 1658-1662
        • Rosenberg R.D.
        • Waugh D.F.
        J. Biol. Chem. 1970; 245: 5049-5056
        • Porath J.
        • Axn R.
        • Ernback S.
        Nature. 1967; 215: 1491-1492
        • Markwabdt F.
        Methods Enzymol. 1970; 19: 924-932
        • Olivecrona T.
        • Egelbud T.
        • Iverius P.H.
        • Lindahl U.
        Biochem. Biophys. Res. Commun. 1971; 43: 524-529
        • Iverius P.-H.
        Biochem. J. 1971; 124: 677-683
        • Kezdy F.J.
        • Lorand L.
        • Miller K.D.
        Bio chemistry. 1965; 4: 2302-2308
        • Lowry O.H.
        • Rosebrough N.J.
        • Farr A.L.
        • Randall R.J.
        J. Biol. Chem. 1951; 193: 265-275
        • Udenfriend S.
        Fluorescence Assays in Biology and Medicine. Academic Press, New York1962: 202-205
        • Davis B.J.
        Ann. N. Y. Acad. Sci. 1964; 121: 404-427
        • Weber K.
        • Osborn M.
        J. Biol. Chem. 1969; 244: 4406-4412
        • Gerendas M.
        Thromb. Diath. Haemorrh. 1960; 4: 56-70
        • Abildgaard U.
        Scand. J. Clin. Lab. Invest. 1967; 19: 190-195
        • Waugh D.F.
        • Rosenberg R.D.
        Thromb. Diath. Haemorrh. 1972; 27: 183-195
        • Scheidegger J.J.
        Ini. Arch. Allergy Appl. Immunol. 1955; 7: 103-110
        • Ouchterlony O.
        Progress in Allergy. 5. S. Karger, Basel1958: 1-78
        • Nerenberg S.T.
        J. Lab. Clin. Med. 1972; 79: 673-678
        • Stanworth R.
        Nature. 1960; 188: 156-157
        • Bennet C.A.
        • Franklin N.L.
        Statistical Analy sis in Chemistry and the Chemical Industry. J. Wiley and Sons, New York1954
        • Loeb J.
        Arch. Sci. Physiol. 1956; 10: 129-142
        • Vesterberg O.
        • Svensson H.
        Acta Chem. Scand. 1966; 20: 820-834
        • Liu W.H.
        • Feingstin G.
        • Osuga D.J.
        • Haynes R.
        • Feeney R.E.
        Biochemistry. 1968; 7: 2886-2892
        • Fagerhol M.
        • Abildgaard U.
        Scand. J. Hematol. 1970; 7: 10-17
        • Yin E.T.
        • Wbssler S.
        • Stoll P.J.
        J. Biol. Chem. 1971; 246: 3712-3719
        • Gladner J.A.
        • Laki K.
        J. Amer. Chem, . Soc. 1958; 80: 1263-1264
        • Green N.M.
        J. Biol. Chem. 1953; 205: 535-551
        • Finkenstadt W.R.
        • Laskowski Jr., M.
        J. Biol. Chem. 1967; 242: 771-773
        • Dlouh X.V.
        • Keil B.
        • Sorm F.
        Biochem. Biophys. Res. Commun. 1968; 31: 66-76
        • Haynes R.
        • Feeney R.E.
        Biochemistry. 1968; 7: 2879-2885
        • Blomback B.
        • Blomback M.
        • Hessel B.
        • Iwanaga S.
        Nature. 1967; 215: 1445-1448
        • Plapp B.V.
        • Moore S.
        • Stein W.H.
        J. Biol Chem. 1971; 246: 939-945
        • Huang W.-Y.
        • Tang J.
        J. Biol. Chem. 1972; 247: 2704-2710
        • Carpenter F.H.
        • Harrington K.T.
        J. Biol. Chem. 1972; 247: 5580-5586
        • Hixson Jr., H.F.
        • Laskowski Jr., M.
        Biochemis try. 1970; 9: 166-170
        • Yin E.T.
        • Wesslbb S.
        • Stoll P.J.
        J. Biol. Chem. 1971; 246: 3703-3711
        • Axen R.
        • Ernback S.
        Eur. J. Biochem. 1971; 18: 351-360
        • Tschesche H.
        • Klein H.
        Z. Physiol. Chem. 1968; 349: 1645-1656
        • Bretscher M.S.
        Nature New Biol. 1971; 231: 229-232
        • Panyim S.
        • Chalkley R.
        J. Biol. Chem. 1971; 246: 755-7560

      Article Info

      Publication History

      Published online: September 25, 1973
      Received: February 5, 1972

      Identification

      DOI: https://doi.org/10.1016/S0021-9258(19)43472-8

      Copyright

      © 1973 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.

      User License

      Creative Commons Attribution (CC BY 4.0) |
      How you can reuse Information Icon
      Creative Commons Attribution (CC BY 4.0)

      Permitted

      • Read, print & download
      • Redistribute or republish the final article
      • Text & data mine
      • Translate the article
      • Reuse portions or extracts from the article in other works
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      ASBMB  ASBMB  ASBMB  ASBMB

      ISSN 0021-9258
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX